|
1
|
Sorger PK: Heat shock factor and the heat
shock response. Cell. 65:363–366. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morano KA and Thiele DJ: Heat shock factor
function and regulation in response to cellular stress, growth, and
differentiation signals. Gene Expr. 7:271–282. 1999.PubMed/NCBI
|
|
3
|
Wang Y, Theriault JR, He H, Gong J and
Calderwood SK: Expression of a dominant negative heat shock
factor-1 construct inhibits aneuploidy in prostate carcinoma cells.
J Biol Chem. 279:32651–32659. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Calderwood SK: Heat shock proteins in
breast cancer progression--a suitable case for treatment? Int J
Hyperthermia. 26:681–685. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmucker S and Sumara I: Molecular
dynamics of PLK1 during mitosis. Mol Cell Oncol. 1:e9545072014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim SA, Yoon JH, Lee SH and Ahn SG:
Polo-like kinase 1 phosphorylates heat shock transcription factor 1
and mediates its nuclear translocation during heat stress. J Biol
Chem. 280:12653–12657. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takai N, Hamanaka R, Yoshimatsu J and
Miyakawa I: Polo-like kinases (Plks) and cancer. Oncogene.
24:287–291. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Knecht R, Elez R, Oechler M, Solbach C,
von Ilberg C and Strebhardt K: Prognostic significance of polo-like
kinase (PLK) expression in squamous cell carcinomas of the head and
neck. Cancer Res. 59:2794–2797. 1999.PubMed/NCBI
|
|
9
|
Takahashi T, Sano B, Nagata T, Kato H,
Sugiyama Y, Kunieda K, Kimura M, Okano Y and Saji S: Polo-like
kinase 1 (PLK1) is overexpressed in primary colorectal cancers.
Cancer Sci. 94:148–152. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim SA, Kwon SM, Yoon JH and Ahn SG: The
antitumor effect of PLK1 and HSF1 double knockdown on human oral
carcinoma cells. Int J Oncol. 36:867–872. 2010.PubMed/NCBI
|
|
11
|
Nakamura Y, Fujimoto M, Fukushima S,
Nakamura A, Hayashida N, Takii R, Takaki E, Nakai A and Muto M:
Heat shock factor 1 is required for migration and invasion of human
melanoma in vitro and in vivo. Cancer Lett. 354:329–335. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yao YD, Sun TM, Huang SY, Dou S, Lin L,
Chen JN, Ruan JB, Mao CQ, Yu FY, Zeng MS, et al: Targeted delivery
of PLK1-siRNA by ScFv suppresses Her2+ breast cancer
growth and metastasis. Sci Transl Med. 4:130ra482012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang S, Zhi D and Huang L: Lipid-based
vectors for siRNA delivery. J Drug Target. 20:724–735. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Simberg D, Weisman S, Talmon Y, Faerman A,
Shoshani T and Barenholz Y: The role of organ vascularization and
lipoplex-serum initial contact in intravenous murine lipofection. J
Biol Chem. 278:39858–39865. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hattori Y, Arai S, Kikuchi T, Ozaki K,
Kawano K and Yonemochi E: Therapeutic effect for liver-metastasized
tumor by sequential intravenous injection of anionic polymer and
cationic lipoplex of siRNA. J Drug Target. 24:309–317. 2016.
View Article : Google Scholar
|
|
16
|
Hattori Y, Arai S, Okamoto R, Hamada M,
Kawano K and Yonemochi E: Sequential intravenous injection of
anionic polymer and cationic lipoplex of siRNA could effectively
deliver siRNA to the liver. Int J Pharm. 476:289–298. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee YJ, Kim EH, Lee JS, Jeoung D, Bae S,
Kwon SH and Lee YS: HSF1 as a mitotic regulator: Phosphorylation of
HSF1 by Plk1 is essential for mitotic progression. Cancer Res.
68:7550–7560. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Seth S, Matsui Y, Fosnaugh K, Liu Y, Vaish
N, Adami R, Harvie P, Johns R, Severson G, Brown T, et al:
RNAi-based therapeutics targeting survivin and PLK1 for treatment
of bladder cancer. Mol Ther. 19:928–935. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jacobs AT and Marnett LJ: HSF1-mediated
BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated
colon cancer cells via stabilization of anti-apoptotic Bcl-2
proteins. J Biol Chem. 284:9176–9183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sakurai Y, Hatakeyama H, Akita H and
Harashima H: Improvement of doxorubicin efficacy using liposomal
anti-polo-like kinase 1 siRNA in human renal cell carcinomas. Mol
Pharm. 11:2713–2719. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kato M, Hattori Y, Kubo M and Maitani Y:
Collagenase-1 injection improved tumor distribution and gene
expression of cationic lipoplex. Int J Pharm. 423:428–434. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang XG, Lu XF, Jiao XM, Chen B and Wu
JX: PLK1 gene suppresses cell invasion of undifferentiated thyroid
carcinoma through the inhibition of CD44v6, MMP-2 and MMP-9. Exp
Ther Med. 4:1005–1009. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang S, Tu K, Fu Q, Schmitt DC, Zhou L,
Lu N and Zhao Y: Multifaceted roles of HSF1 in cancer. Tumour Biol.
36:4923–4931. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fang F, Chang R and Yang L: Heat shock
factor 1 promotes invasion and metastasis of hepatocellular
carcinoma in vitro and in vivo. Cancer. 118:1782–1794. 2012.
View Article : Google Scholar : PubMed/NCBI
|
